NCT05963516

Brief Summary

Purpose: To evaluate the effectiveness of newborn resuscitation feedback supported by a mobile health application called LIVEBORN; secondarily, to evaluate the relative effectiveness of real-time guidance vs debriefing. Participants: Newborns and Nurse midwives Procedures (methods): This is a pre-post interventional trial to evaluate the effectiveness of LIVEBORN feedback. The investigators will use a randomized design to test the relative effectiveness of two modes of feedback: real-time guidance versus debriefing. Given the potential for feedback interventions to have spillover effects, the investigators will randomize by cluster (i.e., facility) rather than by individual. The study will begin with an approximately two-month pilot phase to establish systems for implementation of recommended training and simulation practice and consistent use of LIVEBORN for observations. After these systems have been successfully established, the investigators will initiate the pre-post trial. The control phase will last six months followed by implementation of LIVEBORN feedback in an intervention phase lasting 12 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14,130

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 17, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
27 days until next milestone

Study Start

First participant enrolled

August 23, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 22, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2025

Completed
Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

1.7 years

First QC Date

July 17, 2023

Last Update Submit

August 8, 2025

Conditions

Keywords

ResuscitationHelping Babies BreatheDebriefingReal-Time Guidance

Outcome Measures

Primary Outcomes (2)

  • Mean Duration of Suctioning Among Newborns Not Crying By 30 Seconds

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates who are not crying by 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    First hour after birth

  • Median Duration of Suctioning Among Newborns Not Crying By 30 Seconds

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates who are not crying by 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    First hour after birth

Secondary Outcomes (15)

  • Suctioned For <30 Seconds Among Newborns Not Crying By 30 Seconds

    First hour after birth

  • Mean Time to Bag Mask Ventilation

    First hour after birth

  • Median Time to Bag Mask Ventilation

    First hour after birth

  • Proportion of Newborns Who Receive BMV within the Golden Minute Among All Livebirths Not Crying by 30 Seconds Who Receive BMV

    First hour after birth

  • Proportion of Livebirths Not Crying by 60 Seconds Who Receive BMV

    First hour after birth

  • +10 more secondary outcomes

Study Arms (2)

Real-time Guidance

ACTIVE COMPARATOR

The LIVEBORN app will provide audio-visual guidance to the birth attendant during a resuscitation based on the data inputted by an observer as well as heart rate data from NeoBeat (if used).

Other: LIVEBORN: A Mobile Health Application (app) for Newborn ResuscitationDevice: NeoBeat: Heart Rate Meter for Newborn Resuscitation

Debriefing

ACTIVE COMPARATOR

The LIVEBORN app will support birth attendants in debriefing following a resuscitation based on the data inputted by an observer as well as heart rate data from NeoBeat (if used).

Other: LIVEBORN: A Mobile Health Application (app) for Newborn ResuscitationDevice: NeoBeat: Heart Rate Meter for Newborn Resuscitation

Interventions

LIVEBORN is a mobile health application designed to help providers learn from their clinical practice during newborn resuscitation through real-time guidance and debriefing. Using LIVEBORN, an observer can document events during a resuscitation such as the actions of the provider and when the baby cries. A battery-operated heart rate meter, NeoBeat, measures and sends the newborn's heart rate to the LIVEBORN app via Bluetooth. LIVEBORN integrates data from the observer and NeoBeat to provide audio-visual real-time guidance to the provider during a resuscitation. Following the resuscitation, providers can also debrief using LIVEBORN. The app operates on the Android system and is functional off-line, except for the need for an internet connection to upload data to the cloud for research.

DebriefingReal-time Guidance

NeoBeat is a low-cost device for the measurement of newborn heart rate (HR) that was developed by Laerdal Global Health for use in low-resource settings. It is applied by placing the device around the torso of the newborn. It detects HR accurately, quickly (\<5 sec), is reusable and can be easily disinfected. NeoBeat's dry electrodes detect HR which is digitally displayed and recorded. It uses an impedance system to sense skin contact and motion detection to validate signal quality. It does not require the use of buttons, adhesive, gel or cables and has no disposable parts. A single birth attendant can apply NeoBeat in 2-3 seconds.

DebriefingReal-time Guidance

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • All in-born neonates, either liveborn or intrapartum (i.e., fresh) stillborn, regardless of multiple gestation or maternal complication.

You may not qualify if:

  • Less than 28 weeks completed gestation (or if gestational age is unknown, birth weight \<1,000 grams),
  • outborn,
  • known congenital anomaly,
  • antepartum (i.e., macerated) stillbirth.
  • Nurse midwives employed at a participating health facility who meet the following criteria:
  • All midwives and nurses functioning in the role of a midwife who care for newborns at the time of birth during the course of their regular employment.
  • Unwillingness to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Binza

Kinshasa, Democratic Republic of the Congo

Location

Bondo

Kinshasa, Democratic Republic of the Congo

Location

Kingasani

Kinshasa, Democratic Republic of the Congo

Location

Saint Gabriel

Kinshasa, Democratic Republic of the Congo

Location

MeSH Terms

Interventions

Amyloid

Intervention Hierarchy (Ancestors)

Multiprotein ComplexesMacromolecular SubstancesProteinsAmino Acids, Peptides, and Proteins

Study Officials

  • Jackie Patterson, MD, MPH

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2023

First Posted

July 27, 2023

Study Start

August 23, 2023

Primary Completion

May 22, 2025

Study Completion

June 19, 2025

Last Updated

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

A de-identified dataset will be posted onto a suitable publicly available archive.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be made indefinitely available no later than the acceptance for publication of the main findings from the final dataset.
Access Criteria
In accordance with the selected public website criteria.

Locations